Overview

Intravenous Artesunate and Malaria

Status:
Unknown status
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Intravenous artesunate is egual to quinine in the treatment of severe malaria
Phase:
Phase 4
Details
Lead Sponsor:
University of Khartoum
Collaborators:
Kassala
Sudan
University of Kassala, Sudan
Treatments:
Artemisinins
Artesunate
Quinine